Academic panel to define best practices for outpatient stem cell procedure

A group of orthobiologics experts established a Delphi panel process to set treatment standards for an outpatient stem cell procedure known as bone marrow concentrate.

Advertisement

Three things to know:

1. The panel incorporates specialists from orthopedic surgery, interventional spine, sports medicine and pain management among others.

2. They will break down practice items such as informed consent, the use of image guidance and treatment registry, publishing results and advertising.

3. The panel features specialists from Mayo Clinic in Rochester, Minn.; Hospital for Special Surgery in New York City; Stanford (Calif.) University; and Harvard University in Boston, among others. Christopher Centeno, MD, chief medical officer of Regenexx, organized the panel.

More articles on biologics:
Why Dr. Dominic Thomas Kleinhenz joined University Orthopedics and the biggest obstacle in spine
Dr. Stephen Hochschuler: Future trends in spine – telemedicine, robotics, AI & more
Dr. Christopher Kager: The standout spine procedure in his career, future of biologics & more

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

  • Regenerative medicine company Auragens has opened an orthobiologics division.  Orthopedic surgeon Abdiel Ortiz, MD, will lead the new division, which…

  • So far this year, medtech companies and academic institutions are making key strides in spine biologics. From new product launches…

Advertisement

Comments are closed.